Shareholders meeting

Torrent Pharmaceuticals Limited's 53rd Annual General Meeting (AGM) on June 23, 2026, approved standalone and consolidated financial statements for FY26. Shareholders confirmed an interim dividend of ₹29.00 and declared a final dividend of ₹9.00 per equity share for FY26. Key resolutions also included the re-appointment of Director Samir Mehta, ratification of cost auditor remuneration, and the approval for the issuance of equity shares including convertible bonds/debentures, signaling potential future capital raising.